ALCON INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.94 CHF | -0.52% |
|
+2.44% | +11.12% |
| Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
| Apr. 29 | Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump | MT |
ETFs positioned on Alcon Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.96% | 121 M€ | -.--% | - | |
| 1.24% | 0 M€ | +5.61% | - | |
| 1.04% | 0 M€ | +8.51% | ||
| 0.49% | 6 M€ | -.--% | - | |
| 0.41% | 0 M€ | +7.81% | ||
| 0.36% | 0 M€ | +3.67% | - | |
| 0.34% | 6 M€ | -.--% | ||
| 0.30% | 0 M€ | +5.85% | - | |
| 0.24% | 0 M€ | +3.88% | - | |
| 0.23% | 10 M€ | -3.35% | - | |
| 0.23% | 0 M€ | +3.05% | - | |
| 0.12% | 0 M€ | +7.50% | ||
| 0.11% | 284 M€ | -.--% | ||
| 0.11% | 206 M€ | -.--% | ||
| 0.10% | 23 M€ | -.--% | - | |
| 0.10% | 786 M€ | -.--% | ||
| 0.07% | 607 M€ | +0.05% | - | |
| 0.07% | 1,166 M€ | +0.26% | - | |
| 0.07% | 0 M€ | +16.98% | ||
| 0.05% | 0 M€ | 0.00% | - | |
| 0.05% | 0 M€ | +8.21% | - | |
| 0.04% | 7 M€ | +0.11% | - | |
| 0.04% | 0 M€ | +7.77% | - |
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows:
- ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors;
- vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.)
At the end of 2023, the group operated 19 production sites worldwide.
Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
2024-05-07
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
80.85
USD
Average target price
93.1
USD
Spread / Average Target
+15.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.12% | 39.88B | |
| -2.61% | 18.57B | |
| -14.88% | 2.42B | |
| -11.45% | 1.5B | |
| +24.21% | 1.19B | |
| -34.38% | 778M | |
| -35.31% | 752M | |
| -8.66% | 671M | |
| +26.26% | 511M | |
| +23.80% | 486M |
- Stock Market
- Equities
- ALC Stock
- Funds and ETFs Alcon Inc.